Evaluation of the BodyGuardian End-to-end Remote Monitoring Platform in an Outpatient Heart Failure Population
NCT ID: NCT01975402
Last Updated: 2019-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2013-11-30
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the BodyGuardian Remote Monitoring Platform in Elderly Healthy Subjects
NCT01808053
Remote Monitoring of Multiple Indicators of Heart Failure
NCT04267744
Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals
NCT02337790
Remotely Monitoring Patients With Chronic Conditions in Their Home
NCT03207802
Assess Measurements of Wireless Cardiac Output Device
NCT02252757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable New York Heart Association Class I-III HF (defined as no admissions for \> 1 year)
* Recruited from the Mayo Heart Failure Clinic, including 15 men and 15 women
* Age \> 50 years
* Reside in Olmsted County
Exclusion Criteria
* Dementia
* Overall life expectancy \< 2 months
* Blindness
* Pregnancy or women able to become pregnant
* Skin allergy to adhesives
* Inadequate cell phone coverage (international patients or international travel during study period)
* Documented Ejection Fraction of \>40%
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Preventice
INDUSTRY
National Institute on Aging (NIA)
NIH
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lyle J. Olson, M.D.
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyle J Olson, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Jacksonville, Florida, United States
Mayo Clinic Health System-Eau Claire Hospital, Inc.
Eau Claire, Wisconsin, United States
Mayo Clinic Health System-Franciscan Medical Center
La Crosse, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-005607
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.